MX2022002458A - Metodo de aislamiento de nucleosomas circulantes. - Google Patents
Metodo de aislamiento de nucleosomas circulantes.Info
- Publication number
- MX2022002458A MX2022002458A MX2022002458A MX2022002458A MX2022002458A MX 2022002458 A MX2022002458 A MX 2022002458A MX 2022002458 A MX2022002458 A MX 2022002458A MX 2022002458 A MX2022002458 A MX 2022002458A MX 2022002458 A MX2022002458 A MX 2022002458A
- Authority
- MX
- Mexico
- Prior art keywords
- nucleosomes
- isolating circulating
- circulating nucleosomes
- methods
- disease
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6875—Nucleoproteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6804—Nucleic acid analysis using immunogens
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
- G01N33/57585—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6851—Quantitative amplification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
- C12Q2563/131—Nucleic acid detection characterized by the use of physical, structural and functional properties the label being a member of a cognate binding pair, i.e. extends to antibodies, haptens, avidin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2565/00—Nucleic acid analysis characterised by mode or means of detection
- C12Q2565/50—Detection characterised by immobilisation to a surface
- C12Q2565/531—Detection characterised by immobilisation to a surface characterised by the capture moiety being a protein for target oligonucleotides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Pathology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1912251.4A GB201912251D0 (en) | 2019-08-27 | 2019-08-27 | Method of isolating circulating nucleosomes |
| GBGB1916735.2A GB201916735D0 (en) | 2019-11-18 | 2019-11-18 | Method of isolating circulating nucleosomes |
| GBGB2006547.0A GB202006547D0 (en) | 2020-05-04 | 2020-05-04 | Method of isolating circulating nuccleosomes |
| PCT/EP2020/074026 WO2021038010A1 (en) | 2019-08-27 | 2020-08-27 | Method of isolating circulating nucleosomes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2022002458A true MX2022002458A (es) | 2022-05-19 |
Family
ID=72193486
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2022002458A MX2022002458A (es) | 2019-08-27 | 2020-08-27 | Metodo de aislamiento de nucleosomas circulantes. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US12571051B2 (https=) |
| EP (1) | EP4022312A1 (https=) |
| JP (1) | JP2022545821A (https=) |
| KR (1) | KR20220111246A (https=) |
| CN (1) | CN114901832A (https=) |
| AU (1) | AU2020336928A1 (https=) |
| BR (1) | BR112022003546A2 (https=) |
| CA (1) | CA3152642A1 (https=) |
| IL (1) | IL290879A (https=) |
| MX (1) | MX2022002458A (https=) |
| TW (1) | TW202122799A (https=) |
| WO (1) | WO2021038010A1 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2913665T3 (es) | 2017-09-18 | 2022-06-03 | Santersus Ag | Método y dispositivo para la purificación de sangre a partir de ADN celular libre en circulación |
| EP4041914A1 (en) * | 2019-10-04 | 2022-08-17 | Santersus AG | Method for isolating and analyzing cell free dna |
| TW202238131A (zh) | 2020-11-25 | 2022-10-01 | 比利時商比利時意志有限公司 | 測量無細胞核蛋白染色質片段之方法 |
| TW202242145A (zh) | 2020-12-29 | 2022-11-01 | 比利時商比利時意志有限公司 | 核小體耗盡循環無細胞染色質片段之轉錄因子結合位點分析 |
| GB202108185D0 (en) * | 2021-06-08 | 2021-07-21 | Belgian Volition Sprl | Standardisation of nucleosome assays using biologically derived calibrants |
| WO2023126672A1 (en) | 2021-12-27 | 2023-07-06 | Santersus Ag | Method and device for removal of circulating cell free dna |
| WO2023170298A1 (en) * | 2022-03-11 | 2023-09-14 | Belgian Volition Srl | Differential diagnosis method |
| WO2024049928A1 (en) * | 2022-08-30 | 2024-03-07 | Northeastern University | Epigenetic analysis after single cell interactions using microfluidics |
| EP4639173A1 (en) * | 2022-12-19 | 2025-10-29 | Belgian Volition SRL | Calibration |
| GB202300607D0 (en) | 2023-01-16 | 2023-03-01 | Belgian Volition Srl | Proteins and methods for isolating circulating nucleosomes |
| EP4689160A1 (en) * | 2023-04-03 | 2026-02-11 | Belgian Volition SRL | Recombinant nucleosome materials |
| WO2025007034A1 (en) * | 2023-06-29 | 2025-01-02 | Guardant Health, Inc. | Methods for determining surveillance and therapy for diseases |
| WO2025061853A1 (en) | 2023-09-19 | 2025-03-27 | Belgian Volition Srl | Lateral flow test device |
| WO2025073909A1 (en) | 2023-10-04 | 2025-04-10 | Belgian Volition Srl | Pcr method for detecting ctcf occupied cfdna fragments |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2446292A1 (en) * | 2001-05-04 | 2003-06-26 | Incyte Genomics, Inc. | Nucleic acid-associated proteins |
| GB0319376D0 (en) | 2003-08-18 | 2003-09-17 | Chroma Therapeutics Ltd | Histone modification detection |
| GB201115099D0 (en) * | 2011-09-01 | 2011-10-19 | Belgian Volition Sa | Method for detecting nucleosomes |
| GB201115095D0 (en) | 2011-09-01 | 2011-10-19 | Singapore Volition Pte Ltd | Method for detecting nucleosomes containing nucleotides |
| GB201115098D0 (en) | 2011-09-01 | 2011-10-19 | Belgian Volition Sa | Method for detecting nucleosomes containing histone variants |
| CN104067125B (zh) | 2011-12-07 | 2017-12-26 | 比利时意志有限责任公司 | 用于检测核小体加合物的方法 |
| HK1206055A1 (en) | 2012-03-02 | 2015-12-31 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| AU2015340378B2 (en) * | 2014-10-29 | 2021-08-12 | Belgian Volition Sprl | Method for the enrichment of circulating tumor DNA |
| LT3334841T (lt) * | 2015-08-12 | 2020-02-10 | Cemm - Forschungszentrum Für Molekulare Medizin Gmbh | Nukleorūgščių tyrimo būdai |
| GB201518665D0 (en) * | 2015-10-21 | 2015-12-02 | Singapore Volition Pte Ltd | Method for enrichment of cell free nucleosomes |
| EP4339288A3 (en) * | 2016-03-18 | 2024-06-05 | Caris Science, Inc. | Oligonucleotide probes and uses thereof |
| CA3046007A1 (en) | 2016-12-22 | 2018-06-28 | Guardant Health, Inc. | Methods and systems for analyzing nucleic acid molecules |
| ES2913665T3 (es) * | 2017-09-18 | 2022-06-03 | Santersus Ag | Método y dispositivo para la purificación de sangre a partir de ADN celular libre en circulación |
-
2020
- 2020-08-27 JP JP2022513263A patent/JP2022545821A/ja active Pending
- 2020-08-27 US US17/638,136 patent/US12571051B2/en active Active
- 2020-08-27 AU AU2020336928A patent/AU2020336928A1/en not_active Abandoned
- 2020-08-27 TW TW109129345A patent/TW202122799A/zh unknown
- 2020-08-27 CN CN202080075273.6A patent/CN114901832A/zh active Pending
- 2020-08-27 MX MX2022002458A patent/MX2022002458A/es unknown
- 2020-08-27 WO PCT/EP2020/074026 patent/WO2021038010A1/en not_active Ceased
- 2020-08-27 EP EP20760875.3A patent/EP4022312A1/en active Pending
- 2020-08-27 CA CA3152642A patent/CA3152642A1/en active Pending
- 2020-08-27 KR KR1020227009422A patent/KR20220111246A/ko not_active Withdrawn
- 2020-08-27 BR BR112022003546A patent/BR112022003546A2/pt not_active IP Right Cessation
-
2022
- 2022-02-24 IL IL290879A patent/IL290879A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW202122799A (zh) | 2021-06-16 |
| US12571051B2 (en) | 2026-03-10 |
| JP2022545821A (ja) | 2022-10-31 |
| CN114901832A (zh) | 2022-08-12 |
| AU2020336928A1 (en) | 2022-03-24 |
| KR20220111246A (ko) | 2022-08-09 |
| US20220290252A1 (en) | 2022-09-15 |
| IL290879A (en) | 2022-04-01 |
| CA3152642A1 (en) | 2021-03-04 |
| EP4022312A1 (en) | 2022-07-06 |
| BR112022003546A2 (pt) | 2022-05-17 |
| WO2021038010A1 (en) | 2021-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2022002458A (es) | Metodo de aislamiento de nucleosomas circulantes. | |
| AU2017263886A1 (en) | Automated and manual methods for isolation of extracellular vesicles and co-isolation of cell-free DNA from biofluids | |
| EP3910067C0 (en) | NUCLEIC ACID RELEASE AGENT, NUCLEIC ACID PCR AMPLIFICATION METHOD, AND PCR AMPLIFICATION KIT | |
| EP4286055A3 (en) | Analytical systems and methods for nucleic acid amplification using sample assigning parameters | |
| WO2014106004A3 (en) | High-throughput system and method for identifying antibodies having specific antigen binding activities | |
| MX2016016902A (es) | Metodos para analizar acidos nucleicos de celulas individuales o poblaciones de celulas. | |
| EP3845640A3 (en) | Modified tranposases for improved insertion sequence bias and increased dna input tolerence | |
| HUE069742T2 (hu) | Biológiai laboratóriumi rendszer és eljárás mûködtetésére | |
| EP4151748C0 (en) | ANALYSIS OF MULTIPLE SPATIALLY DIFFERENTIATED NUCLEIC ACIDS FROM ORGANIC SPECIMENS | |
| HK1248286A1 (zh) | 血浆dna的单分子测序 | |
| MY170164A (en) | Aptamer-based multiplexed assays | |
| PH12015502849A1 (en) | Biomarkers for cognitive dysfunction diseases and method for detecting cognitive dysfunction disease using biomarkers | |
| AR089934A1 (es) | Analisis de datos de secuencias de adn | |
| WO2014065889A3 (en) | Multiplexed method for diagnosing classical hodgkin lymphoma | |
| EP4491740A3 (en) | Analysis of chromatin using a nicking enzyme | |
| WO2019143943A3 (en) | Composition and method for concentration and enrichment of nucleic acids | |
| TR201903963T4 (tr) | Hizalama içermeyen sekans analizi kullanılarak bir hedef sekans içindeki mutasyon(lar)ı içeren üyeler için bir popülasyonun taranmasına ait yüksek verimlilik metodu. | |
| BR112019005810A2 (pt) | método para sequenciamento de microbioma melhorado para caracterizar uma afecção relacionada a micro-organismo para um usuário associado a uma amostra biológica, e método para sequenciamento de microbioma melhorado | |
| FI20165634A7 (fi) | Laite ja menetelmät mikro-organismien identifioimiseksi häiritsevästä matriisista | |
| GB2515944A (en) | Peptide arrays | |
| BR112019006862A2 (pt) | dispositivo de análise e método para testagem de uma amostra | |
| MX2018013791A (es) | Metodos y composiciones para caracterizar bacterias resistentes a farmacos a partir de muestras biologicas fijadas con formalina e incluidas en parafina. | |
| TR201819546T4 (tr) | Numune tür kökeni için tespit yöntemleri. | |
| SG11202001088PA (en) | Methods and kits for extracting nucleic acids from paraffin embedded samples | |
| EP3967751A4 (en) | HUMAN CARDIOMYOCYTE SEPARATION REAGENT, CULTURE MEDIUM, SEPARATION PROCEDURE AND CULTURE PROCEDURE |